Choriogonadotropin beta chain precursor
Choriogonadotropin beta chain precursor Brand names, Choriogonadotropin beta chain precursor Analogs
Choriogonadotropin beta chain precursor Brand Names Mixture
- No information avaliable
Choriogonadotropin beta chain precursor Chemical_Formula
C1105H1770N318O336S26
Choriogonadotropin beta chain precursor RX_link
http://www.rxlist.com/cgi/generic/ovidrel.htm
Choriogonadotropin beta chain precursor fda sheet
Choriogonadotropin beta chain precursor msds (material safety sheet)
Choriogonadotropin beta chain precursor Synthesis Reference
No information avaliable
Choriogonadotropin beta chain precursor Molecular Weight
25719.7
Choriogonadotropin beta chain precursor Melting Point
55 oC (Forastieri, H., Ingham, K.C. J. Biol. Chem. 257:7976-7981 (1982))
Choriogonadotropin beta chain precursor H2O Solubility
No information avaliable
Choriogonadotropin beta chain precursor State
Solid
Choriogonadotropin beta chain precursor LogP
-0.258
Choriogonadotropin beta chain precursor Dosage Forms
Solution (Subcutaneous Injection)
Choriogonadotropin beta chain precursor Indication
For the treatment of female infertility
Choriogonadotropin beta chain precursor Pharmacology
Choriogonadotropin alfa is used to treat female infertility, Choriogonadotropin alfa stimulates late follicular maturation and resumption of oocyte meiosis, and initiates rupture of the pre-ovulatory ovarian follicle. Ovidrel is an analogue of Luteinizing Hormone (LH) and binds to the LH/hCG receptor of the granulosa and theca cells of the ovary to effect these changes in the absence of an endogenous LH surge.
Choriogonadotropin beta chain precursor Absorption
No information avaliable
Choriogonadotropin beta chain precursor side effects and Toxicity
No information avaliable
Choriogonadotropin beta chain precursor Patient Information
No information avaliable
Choriogonadotropin beta chain precursor Organisms Affected
Humans and other mammals
